Trueblood Wealth Management’s Merck MRK Stock Holding History

Trueblood Wealth Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$851K	Buy	6,626 +35	+0.5%	+$4.1K	0.3%	111
2026 Q1	$793K	Sell	6,591 -952	-13%	-$110K	0.31%	102
2025 Q4	$794K	Sell	7,543 -452	-6%	-$42.4K	0.31%	104
2025 Q3	$671K	Sell	7,995 -148	-2%	-$12.2K	0.26%	118
2025 Q2	$645K	Sell	8,143 -495	-6%	-$39.3K	0.27%	121
2025 Q1	$775K	Sell	8,638 -5	-0.1%	-$467	0.36%	97
2024 Q4	$860K	Sell	8,643 -4,849	-36%	-$500K	0.42%	75
2024 Q3	$1.53M	Sell	13,492 -264	-2%	-$31.4K	0.77%	31
2024 Q2	$1.7M	Buy	13,756 +396	+3%	+$51K	0.96%	20
2024 Q1	$1.76M	Buy	13,360 +169	+1%	+$20.8K	1.01%	17
2023 Q4	$1.44M	Buy	+13,191	New	+$1.37M	0.9%	23

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Trueblood Wealth Management's MRK Position: Q2 2026 in Review

Trueblood Wealth Management increased its Merck (MRK) stake by 0.53% in Q2 2026, buying an estimated $4.1K and bringing the position to 6,626 shares worth $851K. The position accounts for 0.3% of the portfolio, ranked #111.

Trueblood Wealth Management first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.76M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Trueblood Wealth Management held 6,626 shares of Merck worth $851K as of Q2 2026.
Trueblood Wealth Management bought 35 Merck shares in Q2 2026, an estimated $4.1K.
Merck made up 0.3% of Trueblood Wealth Management's portfolio in Q2 2026, its #111 holding.
Trueblood Wealth Management first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
Trueblood Wealth Management's Merck position peaked at $1.76M in Q1 2024.
1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Trueblood Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.